SE413405B - Analogiforfarande for framstellning av pyridazinonforeningar - Google Patents
Analogiforfarande for framstellning av pyridazinonforeningarInfo
- Publication number
- SE413405B SE413405B SE7415691A SE7415691A SE413405B SE 413405 B SE413405 B SE 413405B SE 7415691 A SE7415691 A SE 7415691A SE 7415691 A SE7415691 A SE 7415691A SE 413405 B SE413405 B SE 413405B
- Authority
- SE
- Sweden
- Prior art keywords
- pyridazinon
- compounds
- preparation
- analogy procedure
- analogy
- Prior art date
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB58726/73A GB1488330A (en) | 1973-12-19 | 1973-12-19 | Dihydropyridazinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7415691L SE7415691L (sv) | 1975-06-23 |
| SE413405B true SE413405B (sv) | 1980-05-27 |
Family
ID=10482281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7415691A SE413405B (sv) | 1973-12-19 | 1974-12-13 | Analogiforfarande for framstellning av pyridazinonforeningar |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3931177A (sv) |
| JP (1) | JPS5093984A (sv) |
| BE (1) | BE823103A (sv) |
| CA (1) | CA1033733A (sv) |
| CH (1) | CH608794A5 (sv) |
| DE (1) | DE2459468A1 (sv) |
| DK (1) | DK142870B (sv) |
| ES (1) | ES433135A1 (sv) |
| FI (1) | FI356974A7 (sv) |
| FR (1) | FR2255070B1 (sv) |
| GB (1) | GB1488330A (sv) |
| HU (1) | HU170633B (sv) |
| IE (1) | IE40428B1 (sv) |
| IL (1) | IL46158A (sv) |
| NL (1) | NL7416578A (sv) |
| SE (1) | SE413405B (sv) |
| SU (1) | SU578872A3 (sv) |
| ZA (1) | ZA747462B (sv) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111936A (en) * | 1974-06-18 | 1978-09-05 | Smith Kline & French Laboratories Limited | Pyridazinethiones |
| US4082843A (en) * | 1975-11-26 | 1978-04-04 | Smith Kline & French Laboratories Limited | 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents |
| CH624395A5 (sv) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag | |
| US4258185A (en) * | 1978-10-17 | 1981-03-24 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridazinone compounds |
| DE2845456A1 (de) * | 1978-10-19 | 1980-08-14 | Merck Patent Gmbh | 6-arylpyridazin-3-one und verfahren zu ihrer herstellung |
| US4281125A (en) * | 1980-05-15 | 1981-07-28 | Diamond Shamrock Corporation | Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates |
| DE3048487A1 (de) * | 1980-12-22 | 1982-07-29 | Cassella Ag, 6000 Frankfurt | Basisch substituierte pyridazine, ihre herstellung und ihre verwendung |
| FI72718C (sv) * | 1981-03-04 | 1987-07-10 | Ciba Geigy Ag | Förfarande för framställning av terapeutiskt verkande, substituerade 6 -(4-morfolino-fenyl)-4,5-dihydro3(2H)-pyridazinoner och deras syraaddi tionssalter. |
| GB8323553D0 (en) * | 1983-09-02 | 1983-10-05 | Smith Kline French Lab | Pharmaceutical compositions |
| JPS6193169A (ja) * | 1984-10-12 | 1986-05-12 | Sankyo Co Ltd | ピリダジノン誘導体及びその製法 |
| GB8426804D0 (en) * | 1984-10-23 | 1984-11-28 | Ciba Geigy Ag | Pyridazinones preparations |
| JPH0629254B2 (ja) * | 1986-09-08 | 1994-04-20 | 帝国臓器製薬株式会社 | ピリダジノン誘導体 |
| DE3934436A1 (de) * | 1989-06-01 | 1991-04-18 | Thomae Gmbh Dr K | 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE19514568A1 (de) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Arylalkyl-pyridazinone |
| KR101059776B1 (ko) | 2001-06-12 | 2011-08-26 | 웰스테트 테라퓨틱스 코포레이션 | 대사 질환의 치료용 화합물 |
| US20070060748A1 (en) * | 2002-11-27 | 2007-03-15 | Hamilton Gregory S | Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| EP1833480A2 (en) * | 2004-11-30 | 2007-09-19 | Artesian Therapeutics, Inc. | Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| US20080090827A1 (en) * | 2004-11-30 | 2008-04-17 | Artesian Therapeutics, Inc. | Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| US8022249B2 (en) | 2005-04-01 | 2011-09-20 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| NZ574873A (en) | 2006-07-25 | 2012-03-30 | Cephalon Inc | Pyridazinone derivatives as h3 inhibitors |
| CN101668732A (zh) * | 2007-04-02 | 2010-03-10 | 同一世界健康研究院 | Cftr抑制剂化合物及其用途 |
| US8354557B2 (en) * | 2008-06-17 | 2013-01-15 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated morpholine derivatives |
| US9346802B2 (en) | 2013-03-15 | 2016-05-24 | Epizyme, Inc. | CARM1 inhibitors and uses thereof |
| KR20160003647A (ko) | 2013-03-15 | 2016-01-11 | 에피자임, 인코포레이티드 | Carm1 억제제 및 이의 용도 |
| EP2970266B1 (en) | 2013-03-15 | 2018-01-31 | Epizyme, Inc. | 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3689652A (en) * | 1970-10-09 | 1972-09-05 | William Vincent Curran | Method of lowering blood pressure in mammals |
| GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
-
1973
- 1973-12-19 GB GB58726/73A patent/GB1488330A/en not_active Expired
-
1974
- 1974-11-21 ZA ZA00747462A patent/ZA747462B/xx unknown
- 1974-11-27 CA CA214,774A patent/CA1033733A/en not_active Expired
- 1974-11-29 IE IE2477/74A patent/IE40428B1/xx unknown
- 1974-11-29 IL IL46158A patent/IL46158A/xx unknown
- 1974-12-05 DK DK634074AA patent/DK142870B/da unknown
- 1974-12-09 BE BE151287A patent/BE823103A/xx not_active IP Right Cessation
- 1974-12-11 FI FI3569/74A patent/FI356974A7/fi unknown
- 1974-12-12 US US05/531,957 patent/US3931177A/en not_active Expired - Lifetime
- 1974-12-13 SE SE7415691A patent/SE413405B/sv unknown
- 1974-12-16 DE DE19742459468 patent/DE2459468A1/de not_active Ceased
- 1974-12-17 CH CH7416775A patent/CH608794A5/xx not_active IP Right Cessation
- 1974-12-17 FR FR7441471A patent/FR2255070B1/fr not_active Expired
- 1974-12-18 SU SU7402088301A patent/SU578872A3/ru active
- 1974-12-18 JP JP49146279A patent/JPS5093984A/ja active Pending
- 1974-12-18 HU HUSI1445A patent/HU170633B/hu unknown
- 1974-12-19 ES ES433135A patent/ES433135A1/es not_active Expired
- 1974-12-19 NL NL7416578A patent/NL7416578A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL46158A (en) | 1978-08-31 |
| JPS5093984A (sv) | 1975-07-26 |
| DE2459468A1 (de) | 1975-07-03 |
| DK634074A (sv) | 1975-08-25 |
| FR2255070A1 (sv) | 1975-07-18 |
| FR2255070B1 (sv) | 1979-09-21 |
| ZA747462B (en) | 1975-12-31 |
| IE40428L (en) | 1975-06-19 |
| DK142870C (sv) | 1981-09-21 |
| CH608794A5 (sv) | 1979-01-31 |
| IL46158A0 (en) | 1975-02-10 |
| ES433135A1 (es) | 1976-11-16 |
| NL7416578A (nl) | 1975-06-23 |
| SE7415691L (sv) | 1975-06-23 |
| BE823103A (fr) | 1975-06-09 |
| US3931177A (en) | 1976-01-06 |
| CA1033733A (en) | 1978-06-27 |
| IE40428B1 (en) | 1979-05-23 |
| AU7572474A (en) | 1976-05-27 |
| SU578872A3 (ru) | 1977-10-30 |
| HU170633B (sv) | 1977-07-28 |
| FI356974A7 (sv) | 1975-06-20 |
| GB1488330A (en) | 1977-10-12 |
| DK142870B (da) | 1981-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE413405B (sv) | Analogiforfarande for framstellning av pyridazinonforeningar | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| SE422943B (sv) | Analogiforfarande for framstellning av penicilliner | |
| SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
| SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
| SE420598B (sv) | Analogiforfarande for framstellning av naftalenderivat | |
| SE411212B (sv) | Forfarande for framstellning av 3-halogen-cefalosporiner | |
| SE417969B (sv) | Forfarande for framstellning av 3-metylencefalosporinforeningar | |
| SE415834B (sv) | Analogiforfarande for framstellning av pyrazolderivat | |
| SE410470B (sv) | Forfarande for framstellning av xyloslosning | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE413404B (sv) | Forfarande for framstellning av pyrazolderivat | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| SE417319B (sv) | Analogiforfarande for framstellning av ergopeptiner | |
| SE7608956L (sv) | Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler | |
| SE420089B (sv) | Analogiforfarande for framstellning av fenoxipropylaminderivat (acetofenoner) | |
| SE421422B (sv) | Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin | |
| SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE411211B (sv) | Forfarande for framstellning av 3-halogencefalosporiner | |
| NO140344C (no) | Fremgangsmaate for fremstilling av nye n2-dansyl-l-argininderivater | |
| SE416809B (sv) | Analogiforfarande for framstellning av d-2-substituerad-6-alkyl-8-substituerade ergoliner |